Patients that are immunosuppressed might be at risk of serious influenza-associated
complications. As a result, multiple guidelines recommend influenza vaccination for patients …

People living with HIV have a higher risk of developing lymphoma. Outcomes for people
living with HIV with relapsed or refractory (r/r) lymphoma remain poor. For this group of …

Background Vaccines against COVID-19 are a powerful tool to control the current SARS-
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …

ContextMany patients infected with human immunodeficiency virus type 1 (HIV-1) and
receiving highly active antiretroviral therapy experience intermittent episodes of detectable …

Objective: To evaluate the safety and immunogenicity of the H1N1 2009 vaccine in HIV-
positive individuals. Design: A single-arm study. Setting: Clinic at the Hospital of the …

When antiretroviral therapy (ART) is administered for long periods to HIV-1-infected patients,
most achieve viral loads that are “undetectable” by standard assay methods (ie, HIV-1 RNA< …

Background Many HIV-1-infected patients on suppressive antiretroviral therapy (ART) have
transiently elevated HIV RNA levels. The clinical significance of these viral blips is uncertain …

The article discusses the recommendations on the proper usage of active and passive
immunization in adults with (Human Immunodeficiency Virus) HIV. It explains HIV and …

INTRODUCTION A major obstacle to an HIV cure is a persistent subset of quiescent,
infected cells, known as the latent reservoir. 1-3 Proviruses in their quiescent state remain …

Antiretroviral therapy (ART) can effectively suppress HIV-1 replication, improving quality of
life and restoring the lifespan of persons living with HIV (PLWH) to near-normal levels …